| "{\"id\": \"1300342\", \"name\": \"TRISTRATA TECHNOLOGY, INC., Plaintiff-Appellee, v. ICN PHARMACEUTICALS, INC., Defendant-Appellant\", \"name_abbreviation\": \"Tristrata Technology, Inc. v. ICN Pharmaceuticals, Inc.\", \"decision_date\": \"2004-06-08\", \"docket_number\": \"No. 04-1388\", \"first_page\": \"341\", \"last_page\": \"341\", \"citations\": \"101 F. App'x 341\", \"volume\": \"101\", \"reporter\": \"West's Federal Appendix\", \"court\": \"United States Court of Appeals for the Federal Circuit\", \"jurisdiction\": \"United States\", \"last_updated\": \"2021-08-10T18:57:26.130768+00:00\", \"provenance\": \"CAP\", \"judges\": \"\", \"parties\": \"TRISTRATA TECHNOLOGY, INC., Plaintiff-Appellee, v. ICN PHARMACEUTICALS, INC., Defendant-Appellant.\", \"head_matter\": \"TRISTRATA TECHNOLOGY, INC., Plaintiff-Appellee, v. ICN PHARMACEUTICALS, INC., Defendant-Appellant.\\nNo. 04-1388.\\nUnited States Court of Appeals, Federal Circuit.\\nJune 8, 2004.\\nRaymond A. Kurz, Principal Attorney, Hogan & Hartson, Washington, DC, for f\\u2019 \\u2019 s \\u2019 \\u2019 Defendant-Appellant.\\nMichael O. Warnecke, Principal Attorney, Mayer, Brown, Chicago, IL, for Plaintiff-Appellee.\", \"word_count\": \"65\", \"char_count\": \"484\", \"text\": \"ORDER\\nThe parties having so agreed, it is\\nORDERED that the proceeding is DISMISSED under Fed. R.App. P. 42(b).\"}" |